Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Recombinant Ketoreductase. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102965403A reveals a novel recombinant ketoreductase method for statin side chains, offering superior purity and simplified downstream processing for pharmaceutical manufacturers.
Patent CN103122355A details a thermostable ketoreductase enabling high-purity chiral alcohol manufacturing with significant cost reduction and supply chain reliability.